Chronic catarrhal gingivitis is diagnosed in 30 to 80 % of children and adolescents. Generalized periodontitis may develop in the absence or insufficient provision of timely treatment and preventive care. An important task is to promptly identify and substantiate pathogenetic treatment of gingivitis and its chronic form, especially given the concomitant somatic diseases.The aim of the study – to evaluate the clinical efficacy of antiseptic conditions, probiotics and immunomodulators in complex treatment of chronic catarrhal gingivitis in children with diabetes type I.Materials and Methods. We examined and treated 54 children, aged 12 years, with chronic catarrhal gingivitis and diabetes type I. The complex of treatment included antiseptic "Dekasan", probiotic "BioGaia ProDentis" and immunostimulant "Imupret."Results and Discussion. In 24 children (80.00 %) of the main group completed elimination of inflammation after improved treatment, in 6 children (20.00 %) revealed improvement in the periodontal tissues. There was marked improvement in oral hygiene in children and significant reducted PMA and CPITN indexes, Pisarev-Shyllyer test. After 3 and 6 months after treatment, there was a positive dynamics of periodontal tissues.Conclusions. Analysis of the clinical examinations reflects the positive dynamics of indicators of periodontal tissues in children with chronic catarrhal gingivitis against diabetes, which confirms the high efficiency of our proposed health care industry.
Epiphyseal Cartilage and Subchondral Bone of Rat Tibia as Early Targets of Diabetes Type I